METHOD OF TREATING MIXED LINEAGE LEUKEMIA GENE-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIAS

Details for Australian Patent Application No. 2003268185 (hide)

Owner DANA-FARBER CANCER INSTITUTE INC. NOVARTIS AG

Inventors FABBRO, Doriano; GRIFFIN, James, Douglas

Pub. Number AU-A-2003268185

PCT Number PCT/US03/26629

PCT Pub. Number WO2005/027910

Filing date 25 August 2003

Wipo publication date 11 April 2005

International Classifications

A61K 031/553 - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61P 035/02 Antineoplastic agents

Event Publications

8 January 2004 Complete Application Filed

26 May 2005 Application Open to Public Inspection

  Published as AU-A-2003268185

11 May 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003268186-COLOR PROFILING USING GRAY BACKING MATERIAL

2003268184-PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3